Bank Of New York Mellon Corp Opiant Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $1,113 - $1,577	117 Added 0.66%	17,796 $191,000
Q2 2022 Aug 15, 2022	BUY	$10.12 - $23.32 $178,911 - $412,274	17,679 New	17,679 $212,000
Q1 2022 May 11, 2022	SELL	$19.54 - $33.59 $152,470 - $262,102	-7,803 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$22.51 - $36.79 $175,645 - $287,072	7,803 New	7,803 $262,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.